University Health Network

Beckman Coulter, Inc.

University of Toronto

Northwestern University

Case Western Reserve University

Allegheny-singer Research Institute

David Hedley

Mark Nitz

Lisa M Willis

Matthew A Lumba

Hanuel Park

Ravi N Vellanki

Landon J Edgar

T Vincent Shankey

Sue Chow

Bradly G Wouters

Mark R Bray

Jacqueline M Mason

Sergei Gulnik

Lidice L Lopez

James W Jacobberger

Vincent T Shankey

Ines Lohse

Patricia Grom

Charles Goolsby

Bradley G Wouters

Stanley Shackney

Susan Chow

A compound of formula (I): as described herein and methods and uses thereof as for mass tagging a biosensor or biologically active material.

Organotellurium compounds, compositions and methods of use thereof

A compound of formula (I) as described herein and methods and uses thereof as probes in the mass tagging of biosensors or biologically active materials for use in mass cytometry analysis of tissue samples such as in the detection, labelling and quantification of oxygen-deprived cells by using, for example, tellurophene-tagged 2-nitroimidazole. 

Assays that can measure the effect of proteasome inhibitors on target cells in a biological sample are provided. The assays include evaluation of the effects of proteasome inhibitors on proteasome activity in cells in a biological sample.

Proteasome inhibition assay and methods of use

The invention is related to a method of treating a subject with pancreatic cancer with administration of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. 

Treatment for pancreatic cancer

Methods and reagents are provided for determining the activation state of a signal transduction pathway signaling protein. There exists a need in the art for methods that can monitor the efficacy of a signal transduction inhibitor in a patient. Other needs exist for detecting and monitoring certain disease or disorders that are associated with aberrant activation of a signal transduction pathway signaling protein. The present assay provides a highly sensitive assay that is also useful in patient populations in which obtaining a large cellular sample is difficult, for example, neonates.

Pan-kinase activation and evaluation of signaling pathways

This invention is directed to a method for preparation of a biological sample for measurement of protein epitopes that allows for the preservation of intracellular protein epitopes and detection of signal transduction pathways based on the ability to capture transient activation states of the epitopes. The method provided by the invention allows for the rapid fixation of biological samples containing red blood cells, to ensure that epitopes of signal transduction molecules and other intracellular protein epitopes are preserved in the active state. The method of the invention further allows for lysis of red blood cells, thereby making it a useful method for cytometric analysis of biological samples, including, for example, whole blood, bone marrow aspirates, peritoneal fluids, and other red blood cell containing samples. The invention also provides a method to recover or 'unmask' epitopes on intracellular antigens that have been made inaccessible by the cross linking fixative necessary to fix the sample. Significantly, the methods of the invention allow preservation and analysis of phospho-epitope levels in biological samples taken directly from patients to determine disease-specific characteristics.

Whole blood preparation for cytometric analysis of cell signaling pathways

Growing community of inventors

Toronto, Canada

David Hedley